Publication | Closed Access

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

Aprepitant Triple TherapyOncologyMedicineMetronomic TherapyPharmacotherapyPharmacologyHigh-dose CisplatinCancer ResearchChinese Patients